These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 278893)

  • 21. Lecithin:cholesterol acyltransferase: role of N-linked glycosylation in enzyme function.
    O K; Hill JS; Wang X; McLeod R; Pritchard PH
    Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):879-84. PubMed ID: 8379944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma LCAT activities in renal allograft recipients.
    Chan MK; Ramdial L; Varghese Z; Persaud JW; Fernando ON; Moorhead JF
    Clin Chim Acta; 1982 Sep; 124(2):187-93. PubMed ID: 6754140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cupric ions on serum and liver cholesterol metabolism.
    Tanaka M; Iio T; Tabata T
    Lipids; 1987 Dec; 22(12):1016-9. PubMed ID: 3451006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesterol ester:lysolecithin transacylation in the aorta.
    Patelski J; Pioruńska-Stolzmann M
    Enzyme; 1979; 24(5):342-7. PubMed ID: 510279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid abnormalities in uremia, dialysis, and transplantation.
    Chan MK; Varghese Z; Moorhead JF
    Kidney Int; 1981 May; 19(5):625-37. PubMed ID: 7026870
    [No Abstract]   [Full Text] [Related]  

  • 26. [Suppression of phosphofructokinase by sera from uremic patients].
    Takara S; Kumano K; Sakai T; Nakamura K
    Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1111-8. PubMed ID: 2949097
    [No Abstract]   [Full Text] [Related]  

  • 27. Cholesterol ester: lysolecithin acyltransferase activity of the aorta.
    Patelski J; Pioruńska M
    Adv Exp Med Biol; 1977; 82():303-5. PubMed ID: 21525
    [No Abstract]   [Full Text] [Related]  

  • 28. Reverse cholesterol transport and hepatic osteodystrophy.
    Zaidi M; Yuen T; Iqbal J
    Cell Metab; 2022 Mar; 34(3):347-349. PubMed ID: 35235770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolidase and prolinase activities in the erythrocytes of patients with chronic uremia.
    Gejyo F; Kishore BK; Arakawa M
    Nephron; 1983; 35(1):58-61. PubMed ID: 6888626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetate intolerance in chronic uremic patients.
    Guarnieri GF; Carretta R; Toigo G; Campanacci L
    Nephron; 1979; 24(5):212-6. PubMed ID: 503262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuraminidase-like activity in sera of uremic anemic patients.
    Levinsky H; Gafter U; Levi J; Allalouf D
    Nephron; 1984; 37(1):35-8. PubMed ID: 6717703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum and erythrocyte glutathione reductase activity in chronic renal failure.
    Melissinos KG; Delidou AZ; Varsou AG; Begietti SS; Drivas GJ
    Nephron; 1981; 28(2):76-9. PubMed ID: 7290275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uraemic lymphocytes: analysis of their nuclease activity.
    Adamiec R; Szewczyk Z; Szmidziński R; Szopa J
    Int Urol Nephrol; 1993; 25(6):603-10. PubMed ID: 8175281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Monoamine oxidase activity in patients with chronic renal failure and in experimental uremia in rats].
    Ksiazek A
    Pol Arch Med Wewn; 1978 Aug; 60(2):147-51. PubMed ID: 714710
    [No Abstract]   [Full Text] [Related]  

  • 35. Cholinesterase levels in uremic man and renal allografted man.
    Hesse VE; Mostert JW; Moore RH; Murphy GP
    J Surg Oncol; 1970; 2(1):69-75. PubMed ID: 4939049
    [No Abstract]   [Full Text] [Related]  

  • 36. Is an increase of deoxyribonucleases activity in uraemic lymphocytes caused by their augmented synthesis in these cells?
    Adamiec R; Szewczyk Z; Szmidziński R; Szopa J
    Clin Chim Acta; 1993 Nov; 221(1-2):15-22. PubMed ID: 8149632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uremic hypertriglyceridemia-impaired removal versus increased production.
    Nitzan M
    Nutr Rev; 1977 Apr; 35(4):95-6. PubMed ID: 854241
    [No Abstract]   [Full Text] [Related]  

  • 38. Hibernating brown bears are protected against atherogenic dyslipidemia.
    Giroud S; Chery I; Arrivé M; Prost M; Zumsteg J; Heintz D; Evans AL; Gauquelin-Koch G; Arnemo JM; Swenson JE; Lefai E; Bertile F; Simon C; Blanc S
    Sci Rep; 2021 Sep; 11(1):18723. PubMed ID: 34548543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol Disturbances and the Role of Proper Nutrition in CKD Patients.
    Gluba-Brzozka A; Franczyk B; Rysz J
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy.
    Michalczyk A; Dołęgowska B; Heryć R; Chlubek D; Safranow K
    Lipids Health Dis; 2019 Apr; 18(1):85. PubMed ID: 30947711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.